Healthcare -
Biotechnology - NASDAQ - US
$ 7.48
2.89 %
$ 511 M
Market Cap
-3.76
P/E
Price Target
Average
265.42%
Revenue Forecast
Estimate
88.87%
EBIT
Estimate
--60.45%
Net Income
Estimate
26.85%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
EyePoint Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for EYPT of $27.3 , with forecasts ranging from
a
low of
$22 to a high of $30 .
EYPT Lowest Price Target
Wall Street Target
22 USD
194.12%
EYPT Average Price Target
Wall Street Target
27.3 USD
265.42%
EYPT Highest Price Target
Wall Street Target
30 USD
301.07%
REVENUE FORECAST
Revenue Forecast Chart EYPT
EBIT FORECAST
EBIT Forecast Chart EYPT
NET INCOME FORECAST
Net Income Chart EYPT